Regular Articles
Epigenetic Repression of Matrix Metalloproteinases in Myofibroblastic Hepatic Stellate Cells through Histone Deacetylases 4: Implication in Tissue Fibrosis

https://doi.org/10.2353/ajpath.2010.100011Get rights and content
Under an Elsevier user license
open archive

Matrix metalloproteinases (MMPs), which are highly expressed in acute injury, are progressively repressed or silenced in fibrotic liver, favoring extracellular matrix accumulation, while the underlying mechanism is largely unknown. Similarly, normal/quiescent hepatic stellate cells (HSCs) express high levels of MMPs in response to injury signals, such as interleukin-1. After transdifferentiation, the myofibroblastic HSCs are incapable of expressing many MMPs; however, the major signaling pathways required for MMP expression are intact, indicating that repression is at the level of the chromatin. Indeed, both the MMP9 and MMP13 genes are inaccessible to transcription factors and RNA polymerase II, in association with impaired histone acetylation in their promoters. In accordance with impaired histone acetylation at the cellular level, histone deacetylase-4 is accumulated during HSC transdifferentiation. Furthermore, ectopic expression of histone deacetylase-4 in quiescent HSCs results in repression of MMP promoter activities as well as endogenous MMP9 protein expression. Thus, our findings suggest that a histone deacetylase-4-dependent mechanism underlies the epigenetic silencing of MMP genes during tissue fibrogenesis.

Cited by (0)

Supported by NIH funding (R01AR051558 and R01DK069418), and the Wright Foundation (Y.-P.H.) The Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis is supported by NIH grant R24AA12885. The USC Research Center for Liver Diseases microscopy subcore is supported by NIH grant P30 DK 048522.

Supplemental material for this article can be found on http://ajp.amjpathol.org.